Leads Clinical Research And Bio Services Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-01-2025
- Paid Up Capital ₹ 0.10 M
as on 03-01-2025
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 91.25%
(FY 2022)
- Profit 135.42%
(FY 2022)
- Ebitda 190.08%
(FY 2022)
- Net Worth 318.83%
(FY 2022)
- Total Assets 112.14%
(FY 2022)
About Leads Clinical Research And Bio Services
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jestin Thomas, Bincy Sony, and Sherin Mathew serve as directors at the Company.
- CIN/LLPIN
U73100KA2011PTC057300
- Company No.
057300
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Feb 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Leads Clinical Research And Bio Services?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jestin Thomas  | Director | 28-Feb-2011 | Current |
| Bincy Sony | Additional Director | 12-Mar-2018 | Current |
| Sherin Mathew | Additional Director | 31-Dec-2020 | Current |
Financial Performance of Leads Clinical Research And Bio Services.
Leads Clinical Research And Bio Services Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 91.25% increase. The company also saw a substantial improvement in profitability, with a 135.42% increase in profit. The company's net worth Soared by an impressive increase of 318.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Leads Clinical Research And Bio Services?
In 2021, Leads Clinical Research And Bio Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Leads Clinical Research And Bio Services?
Unlock and access historical data on people associated with Leads Clinical Research And Bio Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Leads Clinical Research And Bio Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Leads Clinical Research And Bio Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
